Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

benzinga.com/markets/large-cap/25/07/46198535/novo-nordisk-ignored-internal-warnings-on-wegovy-launch-preparedness-report

Novo Nordisk A/S’ (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its obesity drug Wegovy.
As rival Eli Lilly and Co.’s (NYSE:LLY) Zepbound gains momentum, the Danish pharmaceutical giant is grappling with the fallout of those early…

This story appeared on benzinga.com, 2025-07-01 15:05:32.
The Entire Business World on a Single Page. Free to Use →